Wound-healing growth factor, basic FGF, induces Erk1/2-dependent mechanical hyperalgesia
Authors:
- Jan HasenauerJHJan Hasenauer
- Hye-Sook AhnHAHye-Sook Ahn
- Elizabeth K. JosephEJElizabeth K. Joseph
- Jörg IsenseeJIJörg Isensee
- Fabian J. TheisFTFabian J. Theis
- Frank AllgöwerFAFrank Allgöwer
- Jon D. LevineJLJon D. Levine
- Sulayman D. Dib-HajjSDSulayman D. Dib-Hajj
- Stephen G. WaxmanSWStephen G. Waxman
- Tim HuchoTHTim Hucho
- 1 October 2013
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 154 (10) , 2216-2226
Abstract
Growth factors such as nerve growth factor and glial cell line-derived neurotrophic factor are known to induce pain sensitization. However, a plethora of other growth factors is released during inflammation and tissue regeneration, and many of them are essential for wound healing. Which wound-healing factors also alter the sensitivity of nociceptive neurons is not well known. We studied the wound-healing factor, basic fibroblast growth factor (bFGF), for its role in pain sensitization. Reverse transcription polymerase chain reaction showed that the receptor of bFGF, FGFR1, is expressed in lumbar rat dorsal root ganglia (DRG). We demonstrated presence of FGFR1 protein in DRG neurons by a recently introduced quantitative automated immunofluorescent microscopic technique. FGFR1 was expressed in all lumbar DRG neurons as quantified by mixture modeling. Corroborating the mRNA and protein expression data, bFGF induced Erk1/2 phosphorylation in nociceptive neurons, which could be blocked by inhibition of FGF receptors. Furthermore, bFGF activated Erk1/2 in a dose- and time-dependent manner. Using single-cell electrophysiological recordings, we found that bFGF treatment of DRG neurons increased the current-density of NaV1.8 channels. Erk1/2 inhibitors abrogated this increase. Importantly, intradermal injection of bFGF in rats induced Erk1/2-dependent mechanical hyperalgesia. Analyzing intracellular signaling dynamics in nociceptive neurons has proven to be a powerful approach to identify novel modulators of pain. In addition to describing a new sensitizing factor, our findings indicate the potential to investigate wound-healing factors for their role in nociception.Keywords
This publication has 58 references indexed in Scilit:
- Neurogenic inflammation and the peripheral nervous system in host defense and immunopathologyNature Neuroscience, 2012
- Threshold-Free Population Analysis Identifies Larger DRG Neurons to Respond Stronger to NGF StimulationPLOS ONE, 2012
- Quantitative Automated Microscopy (QuAM) Elucidates Growth Factor Specific Signalling in Pain SensitizationMolecular Pain, 2010
- Nociceptors Are Interleukin-1β SensorsThe Journal of Neuroscience, 2008
- PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healingWound Repair and Regeneration, 2008
- GDNF hyperalgesia is mediated by PLCγ, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4‐binding protein versicanEuropean Journal of Neuroscience, 2008
- Roles of Tetrodotoxin (TTX)-Sensitive Na+Current, TTX-Resistant Na+Current, and Ca2+Current in the Action Potentials of Nociceptive Sensory NeuronsThe Journal of Neuroscience, 2002
- Potent Analgesic Effects of GDNF in Neuropathic Pain StatesScience, 2000
- Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behaviorGlia, 1998
- A Distinct Subgroup of Small DRG Cells Express GDNF Receptor Components and GDNF Is Protective for These Neurons after Nerve InjuryThe Journal of Neuroscience, 1998